Company / Total Assets
Abbott Laboratories Total Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$86.7B
FY2025
5-year range
$73.2B / $86.7B
FY2021-FY2025
Trend
+6.5%
vs FY2024
Sector context
#6 of 161
Health Care
What the data says
Among 161 Health Care companies, Abbott Laboratories is in the top 4% for total assets. Total Assets has fluctuated over the past 10 years, ranging from $41.2B in FY2016 to $86.7B in FY2025.
Based on SEC 10-K filings.
$86.7B in FY2025 with a 5-year CAGR of +3.6%. Top quartile in the Health Care sector.
Improved from $73.2B to $86.7B over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- +5.2%
- 5-Year CAGR
- +3.6%
- 10-Year CAGR
- -
Sector benchmark
Top 4% in Health CareTop 4% of 161This company $86.7B Sector average $14.8B
▼
+487.2% above sector average
Key checks
Key Insights
- 5-year CAGR of +3.6%, indicating consistent growth.
- In FY2025, total assets increased 6.5% year-over-year.
- Ranks #6 out of 161 companies in the Health Care sector.
- Lowest total assets in the period was in FY2016.
Company context
Key Data Points
- Strong profit margin: 31.9%
- High earnings quality (cash-backed earnings)
- Strong return on equity: 27.4%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $86.7B | +6.5% |
| FY2024 | $81.4B | +11.2% |
| FY2023 | $73.2B | -1.6% |
| FY2022 | $74.4B | -1.0% |
| FY2021 | $75.2B | +3.6% |
| FY2020 | $72.5B | +6.9% |
| FY2019 | $67.9B | -11.0% |
| FY2018 | $76.3B | +44.8% |
| FY2017 | $52.7B | +27.7% |
| FY2016 | $41.2B | +0.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026